Myotonic Dystrophy Family Registry
Part of paid clinical trials in Oakland, California.
- Sponsor
- Myotonic Dystrophy Foundation
- Study ID
- NCT02398786
- Status
- Recruiting
Conditions
- Congenital Myotonic Dystrophy
- Dystrophia Myotonica
- Dystrophia Myotonica 1
- Dystrophia Myotonica 2
- Myotonia Atrophica
- Myotonia Dystrophica
- Myotonic Dystrophy
- Myotonic Dystrophy 1
- Myotonic Dystrophy 2
- Myotonic Dystrophy, Congenital
- Myotonic Myopathy, Proximal
- PROMM (Proximal Myotonic Myopathy)
- Proximal Myotonic Myopathy
- Steinert Disease
- Steinert Myotonic Dystrophy
- Steinert's Disease
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Patient-entered data — OTHERThis registry provides patient-entered data for future clinical trial and study use.
Study Details
The Myotonic Dystrophy Family Registry (MDFR) is an online, patient-entered database that collects information on myotonic dystrophy (DM) to aid researchers in developing new, effective treatments and help identify participants for research studies and clinical trials.
Key Dates
- Start date
- Feb 28, 2013
- Status verified
- Nov 2024
- Primary completion
- Feb 28, 2030
- Completion
- Feb 28, 2030
Study Design
- Enrollment
- 3,500 participants (estimated)
Primary Outcome Measure
Patient reported outcomes [ Time Frame: 36 months ]
Central Contacts
- Sofia Olmos, PhD415-800-7777
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Myotonic Dystrophy Foundation | Oakland | California | 94612 |
Find similar trials in Oakland, CA
By research site
Related Studies
- Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)Recruiting · Virginia Commonwealth University · La Jolla, California
- Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic DystrophyPHASE2/PHASE3 · Recruiting · AMO Pharma Limited · Little Rock, Arkansas
- DMCRN-02-001: Assessing Pediatric Endpoints in DM1Recruiting · Virginia Commonwealth University · Los Angeles, California
- Study of ATX-01 in Participants With DM1PHASE1/PHASE2 · Recruiting · ARTHEx Biotech S.L. · Los Angeles, California